# ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas

> **NCT00005594** · PHASE2 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 4 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** ISIS 2503

## Key facts

- **NCT ID:** NCT00005594
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07
- **Primary completion:** 2000-12
- **Final completion:** —
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2011-01-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005594, "ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00005594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*